Sixty-three patients with advanced EGFR-mutant lung cancer at 7 Canadian centers, who were being screened for the ASTRIS trial (ClinicalTrials.gov identifier: NCT02474355), participated in this ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, a privately held biotech company advancing innovative cancer diagnostics, announced that Precision Pathology Services, a CAP/CLIA-certified ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--InterVenn Biosciences today announced it has completed clinical and analytical validation in compliance with standards set by the Clinical Laboratory ...
As drug development becomes more complex, so do the demands for accurate, reproducible bioanalytical data to prove their safety and efficacy. Method validation ensures the reliability of ...
PHOENIX, AZ, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- Precision Epigenomics, a biotechnology company advancing epigenetic-based diagnostics, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback